CBRE vs PRCT · P/E 43, rev $35.77B vs rev $224.5M
CBRE Group Inc Class A (CBRE) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Latest reported CBRE revenue for 2024-12-31 was $35.77B. Net income was $1.04B. Revenue was up 12.0% from 2023-12-31 to 2024-12-31. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the CBRE and PRCT stock pages for the full models.
Not investment advice.